| Serial Number | 86955371 |
| Word Mark | ACCEL RESEARCH SITES |
| Filing Date | Monday, March 28, 2016 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 3, 2018 |
| Registration Number | 5435841 |
| Registration Date | Tuesday, April 3, 2018 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 16, 2018 |
| Goods and Services | Business consulting and management in the field of clinical trials in all phases as it relates to pre-study document collection and review, site selection, visits and audits, site compliance, project tracking and monitoring reports, negotiation and administration of investigator grants and clinical trial budgets and contracts, financial and management accounting, distribution, coordination and tracking of clinical trial products and materials, regulatory document processing, laboratory selection and coordination; Business consulting and management in the field of clinical trials in all phases as it relates to managing site and study-specific subject recruitment strategies and programs in the nature of contingency strategies and solutions to address specific project challenges; Business consulting and management in the field of clinical trials in all phases as it relates to managing the development of all study related documents and materials in the nature of study protocols, contracts, budgets, amendments, paper and electronic case report forms, informed consent forms, safety narratives, presentation posters, and training manuals; Business consulting and management in the field of clinical trials in all phases as it relates to managing all aspects of study, drug reconciliation, and inventory and distribution reports; Business management for all aspects of clinical trials in all phases as it relates to managing investigators, coordinators, monitors, technicians, and participants for compliance with clinical protocols and regulations; Business consulting and management in the field of clinical trials in all phases as it relates to management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials in all phases as it relates to ethical reviews, namely, submitting clinical trial protocols to institutional review boards and independent ethics committees on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical trials; Statistical analysis and reporting services for business purposes in the field of clinical trials; Business project management in the field of clinical trials in all phases as it relates to organizing and conducting business meetings of clinical trial investigators; Business management, namely, managing randomization logistics, in the pharmaceutical and biotechnological field for business purposes; Development and implementation of personnel recruitment and retention programs for investigators, coordinators, monitors, technicians and participants for use in clinical trials; Business consulting and management in the field of clinical trials in all phases as it relates to the administration of protocols involving volunteer research patients and the recruiting of such volunteer research patients; Providing data management services in the medical, pharmaceutical and biotechnological field for business purposes |
| Goods and Services | Regulatory affairs, namely, reviewing standards and practices to assure compliance with clinical trial laws and regulations; Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research |
| Disclaimer with Predetermined Text | "RESEARCH SITES" |
| Goods and Services | Medical and scientific research consulting services for others in the field of design, planning, and implementation of clinical trials in all phases; providing quality assurance services in the pharmaceutical and biotechnological industries |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 31, 2016 |
| Primary Code | 035 |
| First Use Anywhere Date | Sunday, May 31, 2015 |
| First Use In Commerce Date | Sunday, May 31, 2015 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 31, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, May 31, 2015 |
| First Use In Commerce Date | Sunday, May 31, 2015 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 31, 2016 |
| Primary Code | 045 |
| First Use Anywhere Date | Sunday, May 31, 2015 |
| First Use In Commerce Date | Sunday, May 31, 2015 |
| Party Name | Clinical Research Holdings, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lake Mary, FL 32746 |
| Party Name | Clinical Research Holdings, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Deland, FL 32720 |
| Party Name | Clinical Research Holdings, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Deland, FL 32720 |
| Event Date | Event Description |
| Wednesday, April 3, 2024 | TEAS SECTION 8 RECEIVED |
| Monday, January 29, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 29, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, January 29, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, January 29, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, January 29, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, April 3, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, April 3, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 16, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 16, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 27, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 6, 2017 | ASSIGNED TO LIE |
| Tuesday, November 28, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 9, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, November 9, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 9, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 9, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, October 23, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 23, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 23, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 19, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 19, 2017 | NON-FINAL ACTION E-MAILED |
| Thursday, October 19, 2017 | NON-FINAL ACTION WRITTEN |
| Thursday, September 28, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 27, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 27, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 24, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 24, 2017 | NON-FINAL ACTION E-MAILED |
| Thursday, August 24, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 2, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, August 2, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 2, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 2, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, February 6, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, February 6, 2017 | NON-FINAL ACTION E-MAILED |
| Monday, February 6, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 11, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 11, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 11, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 15, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, July 15, 2016 | NON-FINAL ACTION E-MAILED |
| Friday, July 15, 2016 | NON-FINAL ACTION WRITTEN |
| Monday, July 11, 2016 | ASSIGNED TO EXAMINER |
| Thursday, March 31, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 31, 2016 | NEW APPLICATION ENTERED |